南昌好抑郁医院排名治疗幻觉去南昌哪家医院好,南昌专治躁郁症医院,南昌发狂症的治疗医院,南昌治抑郁症哪专业,南昌忧郁症得治疗,南昌第十二医院看精神科专业靠谱不,南昌抑郁专科

CANBERRA, April 14 (Xinhua) -- The Australian federal government could struggle to get its carbon tax through parliament, as key independent Member of Parliament (MP) Tony Windsor on Thursday warned the plan may never become a reality.Windsor, who is one of the independents Prime Minister Julia Gillard will rely on to get her carbon tax pass the Parliament, said while climate action will benefit the bush, he will not "vote for something that does nothing"."There is no carbon tax, there may not be a carbon tax," he told ABC News on Thursday morning."The prime minister doesn't have the numbers, as I understand it at the moment."I have a vote, others do as well, so you can never guarantee something before it gets through a minority parliament."Windsor said people in his rural New South Wales electorate were concerned about the lack of detail around the proposed carbon tax.Gillard played down his comments, saying that Windsor, who sits on the multi-party climate change committee, had been "perfectly consistent" in his approach to the carbon price debate."He does believe climate change is real ... that pricing carbon is the best way, an important way, of tackling climate change," Gillard told ABC Radio on Thursday."(But) he's going to look at the (legislative) package and wait to the end and then judge (it)."Gillard added that the Labor government remains determined to introduce a carbon tax from mid-2012 followed by an emissions trading scheme.

BEIJING, Feb. 10 (Xinhua) -- The Chinese currency, or the yuan, on Thursday rose to a fresh high of 6.5849 against the U.S. dollar, according to the China Foreign Exchange Trading System.The central parity rate of the yuan, or RMB, was 1 basis point higher than the previous record of 6.585 set on Feb. 9, the previous trading day.The central parity rate has risen against the dollar for a three consecutive trading days.China's central bank announced on June 19 last year that it would further reform the yuan exchange rate formation mechanism to improve its flexibility.On China's foreign exchange spot market, the yuan can rise or fall 0.5 percent from the central parity rate each trading day.The central parity rate of the RMB against the U.S. dollar is based on a weighted average of prices before the opening of the market each business day.

JINAN, May 14 (Xinhua) -- Chinese scientists said Saturday that they have found a new species of giant theropod dinosaur in the eastern province of Shandong.The new species, described as a close relative of Tyrannosaurus rex (T. rex), has been named "Zhuchengtyrannus magnus". Paleontological experts found it has unique upper jawbones after examining the skull and jawbones discovered in the city of Zhucheng.It was estimated to be about 11 meters long and 4 meters tall, weighing close to 7 tonnes."We discovered two kinds of tyrannosaurus fossils here and the identity of the other one still remains unclear," said Xu Xing, a researcher at the Institute of Vertebrate Paleontology and Paleoanthropology under the Chinese Academy of Sciences."We've named the new genus Zhuchengtyrannus magnus, which means the 'Tyrant from Zhucheng' because the bones were found in Zhucheng," Xu said.The bones were a few centimeters smaller than the similar bones in the largest T. Rex specimen, so there was no doubt that Zhuchengtyrannus was a huge tyrannosaur, Xu said.According to Xu, Zhuchengtyrannus magnus belonged to a specialized group of gigantic theropods called tyrannosaurines which existed in North America and eastern Asia during the Late Cretaceous Period that dated back about 65 to 99 million years.All tyrannosaurs were carnivorous, bipedal animals that generally had small arms and large skulls. Among the tyrannosaurs, the tyrannosaurines were the largest and characterized by having just two fingers on each hand and large powerful jaws to deliver a bone crushing bite. They were likely both predators and scavengers.The fossil quarry in Zhucheng contains one of the largest concentrations of dinosaur bones in the world. At least 10 dinosaur species have been found in three rounds of excavations since the 1960s, including Tyrannosaurus and Hadrosaurs.

BEIJING, Feb. 3 (Xinhua) -- Thursday marked the welcoming of the Chinese Lunar New Year, or Spring Festival. Celebrations for the Year 2011, also Year of the Rabbit, have been held all over the world, making the Chinese New Year a brilliant symbol in the world's culture.The Chinese New Year is a good opportunity for China and the world to get closer and enhance their friendship. The celebrations also provided a precious occasion for people outside China to feel the unique charm of Chinese culture.In New York, the iconic Empire State building was illuminated in red and gold to mark the Chinese New Year.Chinese handicrafts including festive lanterns, florid Spring Festival paintings and red paper-cut were displayed in the windows on the first floor of the iconic 1,454-foot tall building.Martin Corie, a local resident, said the sea of redness and the strong festival flavor made him feel like being in China.In Paris, a colorful parade featuring music and dancing in the 13th arrondissement in the southern part of the city, attracts more than 100,000 people each year.On Wednesday night, or Lunar New Year's Eve, a special program featuring Chinese folk music was broadcast by the national Radio France.In Cairo, a cultural temple fair was held in Al-Azhar Park. Local visitors were greatly attracted by performances of the Chinese Suona horn (a woodwind instrument) and Chinese traditional art "shadow play." They also enjoyed Chinese embroidering and the practice of the traditional Chinese medical science.

WASHINGTON, March 4 (Xinhua) -- New data suggest that the epilepsy drug Topamax (topiramate) and its generic versions increase the risk for the birth defects cleft lip and cleft palate in babies born to women who use the medication during pregnancy, the U.S. Food and Drug Administration (FDA) said Friday in a statement.Before prescribing topiramate, approved to treat certain types of seizures in people who have epilepsy, health care professionals should warn patients of childbearing age about the potential hazard to the fetus if a woman becomes pregnant while using the drug, the FDA said.Topiramate also is approved to prevent migraine headaches, but not to relieve the pain of migraines."Health care professionals should carefully consider the benefits and risks of topiramate when prescribing it to women of childbearing age," said Russell Katz, director of the Division of Neurology Products in the FDA's Center for Drug Evaluation and Research. "Alternative medications that have a lower risk of birth defects should be considered."Cleft lip and cleft palate, collectively called oral clefts, are birth defects that occur when parts of the lip or palate do not completely fuse together early in the first trimester of pregnancy, a time when many women do not know they are pregnant.The defects range from a small notch in the lip to a groove that runs into the roof of the mouth and nose, possibly leading to problems with eating, talking, and to ear infections. Surgery often is performed to close the lip and palate and most children do well after treatment.Data from the North American Antiepileptic Drug (AED) Pregnancy Registry indicate an increased risk of oral clefts in infants exposed to topiramate during the first trimester of pregnancy. Infants exposed to topiramate as a single therapy experienced a 1.4 percent prevalence of oral clefts, compared with a prevalence of 0.38 percent - 0.55 percent in infants exposed to other antiepileptic drugs.Infants of mothers who did not have epilepsy and were not being treated with other antiepileptic drugs had a prevalence of 0.07 percent. Similar data from the United Kingdom Epilepsy and Pregnancy Register supported the North American AED Pregnancy Registry data.According to the FDA, before starting topiramate, pregnant women and women of childbearing potential should discuss other treatment options with their health care professional.